African Regulatory Harmonization Project Cuts Drug Approval Times And Saves Scarce Resources
A pilot project of joint assessments in East Africa has shown that regulatory review times for a number of branded medicines were reduced from one or two years to a median of seven months, representing a reduction of 40-60%. The project was part of the African Medicines Regulatory Harmonization initiative, which is intended to strengthen and align regulatory practices in sub-Saharan Africa. Part one of this article looks at the history of the AMRH, the 2016 Model Law that guides national regulators in implementing their own procedures, and the East African pilot that has shown joint reviews to be feasible at the regional level.
You may also be interested in...
A new agreement between the WHO and the African Union is expected to strengthen efforts to create the new African Medicines Agency, following the endorsement of the AMA treaty earlier this year.
Initiatives to promote information sharing and reliance among developing country regulators are bearing fruit in the Caribbean and Africa, although much works remains to be done, according to speakers at last week’s pre-ICDRA conference in Dublin.